tailieunhanh - Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: A preclinical study

Hepatocellular carcinoma (HCC) is a common malignant tumor with characteristics of poor prognosis, high morbidity and mortality worldwide. In particular, only a few systemic treatment options are available for advanced HCC patients, and include sorafenib and the recently described atezolizumab plus bevacizumab regimen as possible first-line treatments. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN